Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 12/18 04:00:03 pm
117.74 USD   +5.27%
4d ago VERTEX PHARMACE : David Altshuler, M.D., Ph.D., Joins Vertex as Exec..
12/08 S&P 500 MOVERS : Nbr, celg
12/08 NASDAQ 100 MOVE : Vip, celg
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/12/2014 12/15/2014 12/16/2014 12/17/2014 12/18/2014 Date
118.55(c) 112.88(c) 110.855(c) 111.85(c) 117.74(c) Last
1 329 784 2 137 989 2 113 070 2 554 198 2 148 261 Volume
-1.85% -4.78% -1.79% +0.90% +5.27% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
02/05Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 569 M
EBIT 2014 -662 M
Net income 2014 -727 M
Finance 2014 441 M
Yield 2014 -
Sales 2015 1 273 M
EBIT 2015 -54,6 M
Net income 2015 -172 M
Finance 2015 726 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 49,0x
EV / Sales 2015 21,7x
Capitalization 28 319 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
1d ago VERTEX PHARMACEUTICALS : Appoints David Altshuler, M.D., Ph.D. as EVP of Global ..
2d ago VERTEX PHARMACEUTICALS : Findings on Medicinal Chemistry Reported by Investigato..
4d ago VERTEX PHARMACEUTICALS : MA : Change in Directors or Principal Officers (form 8-..
4d ago VERTEX PHARMACEUTICALS : David Altshuler, M.D., Ph.D., Joins Vertex as Executive..
12/08 S&P 500 MOVERS : Nbr, celg
12/08 NASDAQ 100 MOVERS : Vip, celg
12/03 VERTEX PHARMACEUTICALS : Patent Issued for Pyrazolopyrazine Kinase Inhibitors
12/02 U.S. Patents Awarded to Inventors in Pennsylvania (Dec. 2)
More news
Sector news
11m ago PFIZER : Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cint..
21m ago ACTAVIS : to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
1h ago ROCHE BEARER SHARE : Ahead of the Bell: ImmunoGen shares tumble
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF